Granisetron Impurity 7 HCl, with the CAS number 110766-33-1, is a chemical compound that serves as an impurity associated with the antiemetic drug granisetron, which is primarily used to prevent nausea and vomiting caused by chemotherapy and surgery. This impurity is characterized by its hydrochloride salt form, which typically enhances its solubility in aqueous solutions. The compound is likely to exhibit properties similar to those of granisetron, including interactions with serotonin receptors, although its specific pharmacological effects may differ. As an impurity, it is important to monitor its presence in pharmaceutical formulations to ensure safety and efficacy. The characterization of such impurities often involves techniques like high-performance liquid chromatography (HPLC) and mass spectrometry to determine its structure and concentration. Regulatory guidelines necessitate the identification and quantification of impurities to maintain the quality of pharmaceutical products. Overall, Granisetron Impurity 7 HCl is significant in the context of drug development and quality control in the pharmaceutical industry.

Granisetron Impurity 7 HCl

110766-33-1: Granisetron Impurity 7 HCl, with the CAS number 110766-33-1, is a chemical compound that serves as an impurity associated with the antiemetic drug granisetron, which is primarily used to prevent nausea and vomiting caused by chemotherapy and surgery. This impurity is characterized by its hydrochloride salt form, which typically enhances its solubility in aqueous solutions. The compound is likely to exhibit properties similar to those of granisetron, including interactions with serotonin receptors, although its specific pharmacological effects may differ. As an impurity, it is important to monitor its presence in pharmaceutical formulations to ensure safety and efficacy. The characterization of such impurities often involves techniques like high-performance liquid chromatography (HPLC) and mass spectrometry to determine its structure and concentration. Regulatory guidelines necessitate the identification and quantification of impurities to maintain the quality of pharmaceutical products. Overall, Granisetron Impurity 7 HCl is significant in the context of drug development and quality control in the pharmaceutical industry.

CAS 110766-33-1

Granisetron Impurity 7 HCl

rac-Levosimendan Impurity 16

Ref: 4Z-L-4268